BioNTech SE - American Depositary Shares (NQ:BNTX)

95.51 -1.39 (-1.43%)

Delayed Quote Updated: 10:34 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

73 74 Next >

BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update

August 05, 2024

From BioNTech SE

Via GlobeNewswire

What's Going On With BioNTech (BNTX) Shares? ↗

August 01, 2024

BioNTech shares are trading lower by 5.3% during Thursday's session. Vaccine stocks are down after Moderna cut its 2024 outlook due to weak EU sales and increased U.S. competition.

Via Benzinga

Navigating 12 Analyst Ratings For BioNTech ↗

August 01, 2024

Via Benzinga

Moderna Slashes Its Outlook On 'Very Low' European Sales Despite Quarterly Beat ↗

August 01, 2024

Moderna delivered nearly double the sales analysts expected in the second quarter.

Via Investor's Business Daily

BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patients with Advanced Melanoma

July 30, 2024

From BioNTech SE

Via GlobeNewswire

Evaluating BioNTech: Insights From 12 Financial Analysts ↗

June 26, 2024

Via Benzinga

Week In Review: Nanjing Triastek Partners With BioNTech In A $1.2 Billion Drug Development Deal ↗

July 27, 2024

Triastek will develop oral RNA therapeutics with Germany’s BioNTech based on its 3D printing technology. Triastek will receive a $10 million upfront payment and up to $1.2 billion in milestones, plus...

Via Talk Markets

BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024

July 22, 2024

From BioNTech SE

Via GlobeNewswire

European Commission Faces Court Criticism Over COVID Vaccine Contract Transparency Ahead Of Vote on Ursula Von Der Leyen's Reappointment ↗

July 17, 2024

European Commission faces scrutiny over COVID vaccine contract transparency ahead of key vote. Legal challenges and implications discussed.

Via Benzinga

Evaluating BioNTech: Insights From 15 Financial Analysts ↗

June 10, 2024

Via Benzinga

GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B ↗

July 03, 2024

GSK and CureVac restructured their collaboration into a new licensing agreement, prioritizing mRNA vaccine development. GSK gains full control of vaccine candidates for influenza and COVID-19, while...

Via Benzinga

London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents ↗

July 02, 2024

Pfizer and Moderna continue their legal battle over COVID-19 vaccine patents following a mixed ruling by London's High Court, with potential appeals on the horizon and significant financial stakes...

Via Benzinga

Topics Intellectual Property

Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex

July 02, 2024

The biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout.

Via MarketBeat

Topics ETFs

3 Nasdaq Stocks to Sell in July Before They Crash & Burn ↗

July 02, 2024

These are three Nasdaq stocks to sell before their value plunges even further due to broader economic pressures.

Via InvestorPlace

Surprise! 3 Stocks That Are Outperforming Nvidia in 2024. ↗

July 01, 2024

There are more marketplace opportunities than just AI which is why these stocks that are outperforming Nvidia have done so well.

Via InvestorPlace

Topics Artificial Intelligence

3 Dividend Stocks Yielding Over 3% With Multi-Decade Payout Growth Streaks ↗

July 01, 2024

Explore three high-yield dividend stocks that not only offer yields of 3% or more but also boast multiple decades of payout growth.

Via InvestorPlace

AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway ↗

June 27, 2024

The FDA has approved Epkinly as the first subcutaneously administered bispecific antibody for adults with relapsed or refractory follicular lymphoma after two or more lines of prior therapy.

Via Benzinga

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union

June 27, 2024

From Pfizer Inc.

Via Business Wire

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union

June 27, 2024

From BioNTech SE

Via GlobeNewswire

10 Health Care Stocks Whale Activity In Today's Session ↗

June 24, 2024

Via Benzinga

BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT324/DB-1311 in Prostate Cancer

June 24, 2024

From BioNTech SE

Via GlobeNewswire

GameStop And First Solar Were Among The 10 Biggest Large Cap Losers Last Week (June 16-June 22): Are These In Your Portfolio? ↗

June 23, 2024

10 worst-performing large-cap stocks last week: GME, ENPH, ALB, BNTX, ALGN, FLSR, BALL, MBLY, BLD, JBL. Are they in your portfolio?

Via Benzinga

Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment ↗

June 18, 2024

AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a...

Via Benzinga

Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday? ↗

June 17, 2024

BioNTech partner MediLink Therapeutics faces a partial clinical hold from the FDA on the Phase 1 trial of BNT326/YL202 for advanced non-small cell lung cancer and HR+/HER2-negative breast cancer.

Via Benzinga

Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season ↗

June 07, 2024

Moderna has submitted an FDA application for its 2024-2025 Spikevax formula, targeting the prevalent SARS-CoV-2 variant JN.1.

Via Benzinga

Meme Stocks Surge Led by ‘Roaring Kitty’ and Social Media Buzz on Reddit (NYSE: RDDT), GME, DYAI, AMC, PRSO, NVAX

June 06, 2024

Via AB Newswire

Dyadic International Inc. (NASDAQ: DYAI) Hits New 52-Week High Amidst Golden Cross, Bullish Swing Patterns and Bird Flu Concerns

June 06, 2024

Via AB Newswire

What's Going On With Novavax Stock? ↗

June 05, 2024

Novavax, Inc. shares are trading higher Wednesday, and the stock is up by more than 300% over the past month. Here's a look at what's going on.

Via Benzinga

Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership ↗

June 01, 2024

Suzhou MediLink partnered with Germany’s BioNTech to use MediLink’s TMALIN antibody-drug conjugate platform. MediLink will receive an upfront payment of $25 million and up to $1.8 billion in...

Via Talk Markets

Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)

June 01, 2024

From Genmab A/S

Via Business Wire

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

73 74 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.